Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis.
Multiple sclerosis journal - experimental, translational and clinical（2017）
Abstract
These studies indicate that clozapine is an effective immunomodulatory agent with the potential to treat immune-mediated diseases such as MS.
MoreTranslated text
Key words
Experimental autoimmune encephalomyelitis,atypical antipsychotic agents,clozapine,glatiramer acetate,immune modulation,multiple sclerosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined